Cargando…

Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study

Background: Increased prevalence of antibiotic resistance to Helicobacter pylori (H. pylori) infection worldwide has driven the search for a new therapeutic candidate. Recently, sitafloxacin, a novel 4-quinolone agent, has emerged as a new therapeutic option for H. pylori eradication, in Japan. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Youn I, Lee, Sung Min, Chung, Jun-Won, Kim, Kyoung Oh, Kwon, Kwang An, Kim, Yoon Jae, Kim, Jung Ho, Lee, Sun Mi, Jeong, Jin-Yong, Park, Dong Kyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532961/ https://www.ncbi.nlm.nih.gov/pubmed/34680822 http://dx.doi.org/10.3390/antibiotics10101242

Ejemplares similares

Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
por: Choi, Youn I, et al.
Publicado: (2021)

Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea
por: Choi, Youn I, et al.
Publicado: (2019)

Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial
por: Kim, So Jeong, et al.
Publicado: (2019)

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
por: Saito, Yoshimasa, et al.
Publicado: (2019)

Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success
por: Kim, Beom Jin, et al.
Publicado: (2019)

Circadian rhythm disruption is associated with an increased risk of sarcopenia: a nationwide population-based study in Korea
por: Choi, Youn I, et al.
Publicado: (2019)

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
por: Yoon, Kyu-Hyun, et al.
Publicado: (2014)

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
por: Sue, Soichiro, et al.
Publicado: (2021)

Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
por: Kim, Sung Eun, et al.
Publicado: (2015)

Two Cases of Russell Body Gastritis Treated by Helicobacter pylori Eradication
por: Yoon, Jung Bin, et al.
Publicado: (2012)

Long-term Effects of the Eradication of Helicobacter pylori on Metabolic Parameters, Depending on Sex, in South Korea
por: Park, Jaehyung, et al.
Publicado: (2023)

Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
por: Kim, Beom Jin, et al.
Publicado: (2016)

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
por: Gong, Eun Jeong, et al.
Publicado: (2014)

Helicobacter pylori eradication in renal transplant candidates
por: Maioli, Mariana E., et al.
Publicado: (2022)

Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: A cross-sectional nationwide multicenter study
por: Lim, Seon Hee, et al.
Publicado: (2018)

The Prevalence of Multidrug Resistance of Helicobacter pylori and Its Impact on Eradication in Korea from 2017 to 2019: A Single-Center Study
por: Park, Jae Yong, et al.
Publicado: (2020)

Developing Operational Definitions Related to Helicobacter pylori Eradication Therapy
por: Park, Chan Hyuk, et al.
Publicado: (2023)

The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
por: Chung, Kwang Hyun, et al.
Publicado: (2014)

Effect of Helicobacter pylori Eradication on Functional Dyspepsia
por: Kim, Sung Eun, et al.
Publicado: (2013)

Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis
por: Yoon, Hyuk, et al.
Publicado: (2017)

Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
por: Yun, Sang-Pil, et al.
Publicado: (2012)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura
por: Hwang, Jae Jin, et al.
Publicado: (2016)

Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication
por: Yoon, Jai Hoon, et al.
Publicado: (2012)

Effect of Helicobacter pylori Eradication on Body Weight: A Multicenter Propensity Score-matched Analysis in Korea
por: Kim, Jong Wook, et al.
Publicado: (2023)

Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H. pylori Eradication Rates in a Single Center in Korea
por: An, Byoungrak, et al.
Publicado: (2013)

Eradication of Helicobacter pylori Increases Ghrelin mRNA Expression in the Gastric Mucosa
por: Lee, Eon Sook, et al.
Publicado: (2010)

Effect of β-caryophyllene from Cloves Extract on Helicobacter pylori Eradication in Mouse Model
por: Jung, Da Hyun, et al.
Publicado: (2020)

The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication
por: Choe, Younghee, et al.
Publicado: (2022)

Evidence of Bisphosphonate-Conjugated Sitafloxacin Eradication of Established Methicillin-Resistant S. aureus Infection with Osseointegration in Murine Models of Implant-Associated Osteomyelitis
por: Xie, Chao, et al.
Publicado: (2023)

Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. aureus infection with osseointegration in murine models of implant-associated osteomyelitis
por: Ren, Youliang, et al.
Publicado: (2023)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015)

Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
por: Park, Hyeonsoo, et al.
Publicado: (2020)

Clinical outcomes and safety of high-resolution manometry guided superficial partial circular muscle myotomy in per-oral endoscopic myotomy for Jackhammer esophagus: Two cases report
por: Choi, Youn I, et al.
Publicado: (2019)

Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates
por: Huh, Cheal Wung, et al.
Publicado: (2016)

Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura
por: Tag, Hee Sang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fhbmqqadml1al5du46frl8mk0l